BioSpace News Archive

Infusion therapy involves direct delivery of medication in the bloodstream through intravenous route for immediate relief of pain or in case where a patient is unable to swallow medication.

The prevalence of malaria in tropical countries has been troublesome to the entire world, contributing to millions of deaths over the last ten years.

The global bioresorable implants market is gaining traction, owing to the convenience it provides to the healthcare sector in improving the damaged and injured biological structures.

Exact Sciences Corp. announced that the company has scheduled its virtual annual stockholders meeting and second quarter 2020 earnings call.

UROCAM Inc. is pleased to announce it has received Health Canada Approval of the COVID-19 GeneFinder™ Test Kit and is now making the test available for distribution in Canada.

AstraZeneca and Merck announced that LYNPARZA has been approved in the European Union as a monotherapy for the maintenance treatment of adult patients with germline BRCA1/2 mutations who have metastatic adenocarcinoma of the pancreas and have not progressed after a minimum of 16 weeks of platinum treatment within a first-line chemotherapy regimen.

Luminex Corporation announced 2nd quarter 2020 revenues of between $109 and $110 million, up more than 30% over the 2nd quarter of 2019.

Agreement aims to expedite local biomarker testing of NSCLC patients eligible for entrectinib in Japan

APEIRON to utilize MaxCyte’s ExPERT® platform for siRNA-based cell therapy APN401 targeting solid tumors and secures manufacturing for upcoming clinical trials

Evotec SE announced that Evotec has added significant opportunity for further, long-term growth of its Toulouse-based operations by taking over “Biopark by Sanofi”.